Analysis of survival impact of lymphadenectomy in endometrial cancer patients received adjuvant chemotherapy at intermediate/high risk of progression.

Analysis of survival impact of lymphadenectomy in endometrial cancer patients received adjuvant chemotherapy at intermediate/high risk of progression. - JGOG2043-A4

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046209

Enrollment

780

Registered

2021-12-01

Start date

2021-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Intermediate/high risk endometrial cancer patient who were enrolled in the JGOG2043 trial

Exclusion criteria

Exclusion criteria: Patient without registration of the number of resected lymph node

Design outcomes

Primary

Measure	Time frame
Relapse-free survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactKonno Yosuke

Hokkaido University Hospital Department of Gynecology

konsuke013@gmail.com011-716-1161

Outcome results